Inhibitors of Aurora kinases for the treatment of cancer

被引：11
|
作者：
Fancelli, D [1 ]
Moll, J [1 ]
机构：
[1] BU Oncol, Nerviano Med Sci, I-20014 Nerviano, Italy
来源：
EXPERT OPINION ON THERAPEUTIC PATENTS | 2005年 / 15卷 / 09期
关键词：
Aurora kinase; cancer treatment; inhibitor; mitosis;
D O I：
10.1517/13543776.15.9.1169
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Aurora protein kinases are key players in different steps during mitosis and their activity is required for correct cell division. The inhibition of Aurora kinases is regarded as a promising approach for the development of novel anticancer agents. In the last few years several templates for ATP-competitive kinase inhibition have been successfully developed towards the inhibition of Aurora kinases, and the first compounds have recently entered clinical studies. This review summarises the patent literature up until March 2005 and the characteristics of the low molecular weight Aurora inhibitors described so far.
引用
收藏
页码：1169 / 1182
页数：14
相关论文
共 50 条
  • [21] Hydrosoluble Benzo[e]pyridoindolones as Potent Inhibitors of Aurora Kinases
    Ly-Thuy-Tram Le
    Hong-Lien Vu
    Naud-Martin, Delphine
    Bombled, Marianne
    Chi-Hung Nguyen
    Molla, Annie
    CHEMMEDCHEM, 2013, 8 (02) : 289 - 296
  • [22] Recent advances in the development of Aurora kinases inhibitors in hematological malignancies
    Choudary, Iqra
    Barr, Paul M.
    Friedberg, Jonathan
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2015, 6 (06) : 282 - 294
  • [23] Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinases
    Curtin, Michael L.
    Heyman, H. Robin
    Frey, Robin R.
    Marcotte, Patrick A.
    Glaser, Keith B.
    Jankowski, James R.
    Magoc, Terrance J.
    Albert, Daniel H.
    Olson, Amanda M.
    Reuter, David R.
    Bouska, Jennifer J.
    Montgomery, Debra A.
    Palma, Joann P.
    Donawho, Cherrie K.
    Stewart, Kent D.
    Tse, Chris
    Michaelides, Michael R.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (14) : 4750 - 4755
  • [24] Aurora kinases
    Zhang, Xin
    CURRENT BIOLOGY, 2008, 18 (04) : R146 - R148
  • [25] Aurora kinases
    Bolanos-Garcia, VM
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2005, 37 (08): : 1572 - 1577
  • [26] De-regulation of aurora kinases by oncogenic HPV; implications in cancer development and treatment
    Oladipo, Kemi Hannah
    Parish, Joanna L.
    TUMOUR VIRUS RESEARCH, 2025, 19
  • [27] Solid Cancer Treatment With Aurora Kinase Inhibitors: Towards a Personalized Medicine
    Ulisse, Salvatore
    EBIOMEDICINE, 2017, 25 : 18 - 19
  • [28] THE ONGOING ROLL-OUT OF AURORA KINASE INHIBITORS IN CANCER TREATMENT
    Dotan, E.
    Cohen, R. B.
    DRUGS OF THE FUTURE, 2010, 35 (10) : 845 - 858
  • [29] Inhibitors of cyclin dependent kinases: Useful targets for cancer treatment
    Sharma, P. Sapra
    Sharma, R.
    Tyagi, R.
    CURRENT CANCER DRUG TARGETS, 2008, 8 (01) : 53 - 75
  • [30] Shared and separate functions of polo-like kinases and aurora kinases in cancer
    Susanne M. A. Lens
    Emile E. Voest
    René H. Medema
    Nature Reviews Cancer, 2010, 10 : 825 - 841
12345